Physician profile
Tammy Phan
NPI 1255693263
$2,663.14
in general payments reported to CMS, 2019-2025
12 companies · $76.58 in 2025
The $76.58 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,149 · 2020: $122 · 2021: $517 · 2022: $550 · 2023: $54.62 · 2024: $194 · 2025: $76.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $290 · Education: $35.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $289.64 |
| Education | $35.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,125.71 | 2019-2025 | Precision7 |
| Bausch & Lomb Americas INC. | $282.49 | 2022-2025 | Miebo |
| Kala Pharmaceuticals, INC. | $264.72 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $240.76 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $229.47 | 2019-2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $186.24 | 2021-2022 | |
| Allergan, INC. | $94.39 | 2022 | |
| Biotissue Holdings INC. | $70.87 | 2024 | |
| Coopervision INC. | $66.02 | 2024 | Paragon Crt |
| Novartis Pharmaceuticals Corporation | $49.17 | 2021-2022 | |
| Harrow Eye, LLC | $39.39 | 2024 | Vevye |
| Horizon Therapeutics Plc | $13.91 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tammy Phan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.